Clinical Trials Browser

Interventional × Uterine Cervical Neoplasms × Hydralazine × Clear all

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT00532818 2009-03-30

Hydralazine Valproate for Cervical Cancer

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT00404326 2006-11-28

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms